Safety and efficacy of MIKE-1 in patients with advanced pancreatic cancer: a study protocol for an open-label phase I/II investigator-initiated clinical trial based on a drug repositioning approach that reprograms the tumour stroma.
Saved in:
| Title: | Safety and efficacy of MIKE-1 in patients with advanced pancreatic cancer: a study protocol for an open-label phase I/II investigator-initiated clinical trial based on a drug repositioning approach that reprograms the tumour stroma. |
|---|---|
| Authors: | Mizutani, Yasuyuki1,2 (AUTHOR), Iida, Tadashi1,2 (AUTHOR), Ohno, Eizaburo1 (AUTHOR), Ishikawa, Takuya1 (AUTHOR), Kinoshita, Fumie3 (AUTHOR), Kuwatsuka, Yachiyo3 (AUTHOR), Imai, Miwa3 (AUTHOR), Shimizu, Shinobu3 (AUTHOR), Tsuruta, Toshihisa3 (AUTHOR), Enomoto, Atsushi2 (AUTHOR), Kawashima, Hiroki4 (AUTHOR) h-kawa@med.nagoya-u.ac.jp, Fujishiro, Mitsuhiro1,5 (AUTHOR) |
| Source: | BMC Cancer. 2/24/2022, Vol. 22 Issue 1, p1-11. 11p. |
| Database: | Academic Search Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| ISSN: | 14712407 |
|---|---|
| DOI: | 10.1186/s12885-022-09272-2 |
